Research Profile

The research profile of the Faculty of Medicine Dresden Carl Gustav Carus (MFD) has developed from a broad spectrum of smaller research projects to three impressive research focuses.

These key areas are:

• Oncological diseases - Our passion lies in exploring cancer diseases to discover innovative approaches in cancer therapy.
• Metabolic diseases - We are committed to a better understanding and combating the impact of metabolic diseases, especially diabetes.
• Neurological and psychiatric diseases - Research into neurological and psychiatric diseases is a cornerstone of our mission to promote the well-being of people.

In these key areas, Dresden University Medicine has developed exceptional performance in both research and patient care. We have achieved a critical mass that enables a seamless connection between basic research and clinical application.

The success of our strategic orientation, which is supported by both MFD and Dresden University Hospital Carl Gustav Carus, is reflected in our collaboration with the German Centers for Health Research. We are proud to have successfully acquired sites of the German Consortium for Translational Cancer Research (DKTK) as well as the National Center for Tumor Diseases (NCT), the German Center for Diabetes Research (DZD), the German Center for Neurodegenerative Diseases (DZNE) and the German Center for Child and Adolescent Health (DZKJ).

Our three key areas are complemented by four highly interconnected clusters, highlighting our interdisciplinary approach and passion for pioneering research. Welcome to the exciting world of Dresden University Medicine, where research and innovation go hand in hand to promote the health and well-being of our society.

Some of our recent and most exciting large-scale research projects at MFD (31.12.2023):

SEMECO (Secure Medical Microsystems and Communications) - A pioneering cluster funded by the German Federal Ministry of Education and Research (BMBF) that focuses on the security of medical microsystems and communication systems.

ODELIA (Open Consortium for Decentralized Medical Artificial Intelligence) - An EU-funded project that researches and promotes the decentralized use of medical artificial intelligence.

GENIAL (Understanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma) - Another EU-funded project focusing on understanding the interactions between genes and environmental factors in alcohol-related hepatocellular carcinoma.

CYMEDSEC (Enhanced cybersecurity for networked medical devices through optimization of guidelines, standards) - An EU-funded project that focuses on improving cybersecurity for networked medical devices through the optimization of guidelines and standards.

LOSYSINCHRON (Local and systemic mechanisms for metabolic inflammation chronicity) - Another EU-funded project investigating local and systemic mechanisms for metabolic inflammation chronicity.

PACETHERAPY (Therapies for Pathological Cell Extrusion) - A BMBF-funded project researching innovative therapeutic approaches for the treatment of pathological cell extrusion.

PATH (PERSONAL MASTERY HEALTH & WELLNESS DATA) - Another BMBF-funded project focusing on the collection and use of health and wellness data at a personal level.

VersorgungsNetz SichereGeburt - A project funded by the German Federal Ministry of Health (BMG) that focuses on safety in obstetrics.

Key areas (As of: December 31, 2023):

Interconnected cluster (As of: December 31, 2023)​​​​​​​:

Third-party funding income of the Faculty of Medicine Carl Gustav Carus: 

Note: The Transparency Act requires institutions such as TU Dresden to disclose third-party funding providers. In order to avoid bureaucratic effort and at the same time ensure legal certainty with regard to transparency, disclosure is made on the TUD website.